MERIT MEDICAL SYSTEMS INC Research and Development Asset Acquired Other than Through Business Combination, Written-off
MERIT MEDICAL SYSTEMS INC (MMSI) reported Research and Development Asset Acquired Other than Through Business Combination, Written-off of $1.55 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff · last filed 2026-02-24
- MERIT MEDICAL SYSTEMS INC research and development asset acquired other than through business combination, written-off for the quarter ending 2023-12-31 was $0.00.
- MERIT MEDICAL SYSTEMS INC research and development asset acquired other than through business combination, written-off for the quarter ending 2023-09-30 was $0.00.
- MERIT MEDICAL SYSTEMS INC research and development asset acquired other than through business combination, written-off for the quarter ending 2023-06-30 was $1.55M, a 76.77% decline year-over-year.
- MERIT MEDICAL SYSTEMS INC research and development asset acquired other than through business combination, written-off for the quarter ending 2022-12-31 was $0.00.
- MERIT MEDICAL SYSTEMS INC research and development asset acquired other than through business combination, written-off for fiscal 2023 was $1.55M, a 76.77% decline from fiscal 2022.
- MERIT MEDICAL SYSTEMS INC research and development asset acquired other than through business combination, written-off for fiscal 2022 was $6.67M.
- MERIT MEDICAL SYSTEMS INC research and development asset acquired other than through business combination, written-off for fiscal 2020 was $250.00K, a 52.38% decline from fiscal 2019.
- MERIT MEDICAL SYSTEMS INC research and development asset acquired other than through business combination, written-off for fiscal 2019 was $525.00K, a 18.48% decline from fiscal 2018.
| Period end | Research and Development Asset Acquired Other than Through Business Combination, Written-off 3 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 6 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 9 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 12 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $1.55M derived: sum of 3 quarters · filed 2026-02-24 | $1.55M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $1.55M derived: sum of 2 quarters · filed 2024-10-30 | $1.55M 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | $1.55M 10-Q · filed 2024-08-01 | $1.55M 10-Q · filed 2024-08-01 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $6.67M derived: sum of 3 quarters · filed 2025-02-25 | $6.67M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $6.67M derived: sum of 2 quarters · filed 2023-10-26 | $6.67M 10-Q · filed 2023-10-26 | ||
| 2022-06-30 | $6.67M 10-Q · filed 2023-07-28 | $6.67M 10-Q · filed 2023-07-28 | |||
| 2020-12-31 | $250.00K 10-K · filed 2023-02-24 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $500.00K derived: sum of 3 quarters · filed 2022-03-01 | $525.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $500.00K derived: sum of 2 quarters · filed 2020-11-05 | $525.00K 10-Q · filed 2020-11-05 | $787.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $500.00K 10-Q · filed 2020-08-06 | $525.00K 10-Q · filed 2020-08-06 | $787.00K derived: sum of 3 quarters · filed 2021-03-01 | $862.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $25.00K 10-Q · filed 2020-05-11 | $287.00K derived: sum of 2 quarters · filed 2021-03-01 | $362.00K derived: sum of 3 quarters · filed 2021-03-01 | $668.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $262.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $337.00K derived: sum of 2 quarters · filed 2021-03-01 | $643.00K derived: sum of 3 quarters · filed 2021-03-01 | $644.00K 10-K · filed 2021-03-01 | |
| 2018-09-30 | $75.00K 10-Q · filed 2019-11-08 | $381.00K derived: sum of 2 quarters · filed 2019-11-08 | $382.00K 10-Q · filed 2019-11-08 | $381.00K derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $306.00K 10-Q · filed 2019-08-09 | $306.00K 10-Q · filed 2019-08-09 | $306.00K derived: sum of 3 quarters · filed 2020-03-02 | $12.37M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-03 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $12.06M derived: sum of 3 quarters · filed 2020-03-02 | $12.14M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $12.06M derived: sum of 2 quarters · filed 2020-03-02 | $12.14M derived: sum of 3 quarters · filed 2020-03-02 | $12.14M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $12.06M 10-Q · filed 2018-11-09 | $12.14M derived: sum of 2 quarters · filed 2018-11-09 | $12.14M 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | $75.00K 10-Q · filed 2018-08-09 | $75.00K 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $361.00K derived: sum of 2 quarters · filed 2019-03-01 | $461.00K derived: sum of 3 quarters · filed 2019-03-01 | $461.00K 10-K · filed 2019-03-01 | |
| 2016-09-30 | $300.00K 10-Q · filed 2016-11-09 | $400.00K derived: sum of 2 quarters · filed 2017-08-07 | $400.00K 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | $100.00K 10-Q · filed 2017-08-07 | $100.00K 10-Q · filed 2017-08-07 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.00M derived: sum of 2 quarters · filed 2018-03-01 | $1.00M 10-K · filed 2018-03-01 | ||
| 2015-09-30 | $1.00M 10-Q · filed 2016-11-09 | $1.00M 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-08 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 4 quarters · filed 2015-03-05 | |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 3 quarters · filed 2015-03-05 | $275.00K derived: sum of 4 quarters · filed 2015-03-05 | |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-10 | $0.00 derived: sum of 2 quarters · filed 2015-03-05 | $275.00K derived: sum of 3 quarters · filed 2015-03-05 | $2.27M derived: sum of 4 quarters · filed 2015-03-05 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | $275.00K derived: sum of 2 quarters · filed 2015-03-05 | $2.27M derived: sum of 3 quarters · filed 2015-03-05 | $2.45M 10-K · filed 2015-03-05 | |
| 2012-09-30 | $275.00K 10-Q · filed 2013-11-12 | $2.27M derived: sum of 2 quarters · filed 2013-11-12 | $2.45M 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $2.00M 10-Q · filed 2013-08-09 | $2.17M 10-Q · filed 2013-08-09 | |||
| 2012-03-31 | $175.00K 10-Q · filed 2013-05-10 | ||||
| 2011-12-31 | $5.84M 10-K · filed 2014-03-12 | $4.90M 10-K · filed 2012-02-29 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |